EUVIMEDEUVIMED entdecken
Crossref

The Role of Circulating Extracellular Vesicles in Hemophilia

Roza Chaireti, Jovan P Antovic, Iva Pruner iD

Seminars in Thrombosis and Hemostasis · 14.04.2026

DOI: 10.1055/a-2845-0232 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Seminars in Thrombosis and Hemostasis, online erschienen am 14.04.2026. Verfasst von Roza Chaireti und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AbstractHemophilia is a rare inherited bleeding disorder caused by a deficiency of factor VIII or IX, leading to insufficient thrombin generation and impaired clot formation. While advances in replacement and nonfactor therapies have improved patient outcomes, challenges such as inhibitor development, joint disease, and breakthrough bleeding persist. Extracellular vesicles (EVs) are small membrane-bound particles released from all kinds of cells and have emerged as key mediators of coagulation, vascular integrity, and immune responses. In hemophilia, EVs provide procoagulant surfaces, carry tissue factor and phosphatidylserine, and may stabilize clot structure, partially compensating for deficient coagulation. Clinical studies further suggest that EV levels and composition are altered by factor replacement or bypassing agents, indicating their role as biomarkers of treatment response. Beyond their diagnostic potential, engineered EVs are being explored as innovative therapeutic tools capable of delivering clotting factors and modulating joint inflammation. This review outlines current knowledge on circulating EVs in hemophilia, emphasizing their mechanistic roles, clinical evidence, and therapeutic potential.

Autor:innen und Institutionen

  • Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.
  • Department of Medicine, Solna, Karolinska Institute, Stockholm, Sweden.
  • Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden.
  • Department of Clinical Chemistry, Karolinska University Hospital, Stockholm, Sweden.
  • Center for Clinical and Translational Research, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, United States.

ORCID-Profile: Iva Pruner

Zitieren

APA

Chaireti, R., Antovic, J. P., & Pruner, I. (2026). The Role of Circulating Extracellular Vesicles in Hemophilia. Seminars in Thrombosis and Hemostasis. https://doi.org/10.1055/a-2845-0232

Vancouver

Chaireti R, Antovic JP, Pruner I. The Role of Circulating Extracellular Vesicles in Hemophilia. Seminars in Thrombosis and Hemostasis. 2026. doi:10.1055/a-2845-0232

BibTeX
@article{Chaireti2026,
  author = {Chaireti, Roza and Antovic, Jovan P and Pruner, Iva},
  title = {The Role of Circulating Extracellular Vesicles in Hemophilia},
  journal = {Seminars in Thrombosis and Hemostasis},
  year = {2026},
  doi = {10.1055/a-2845-0232}
}
Kostenlos starten →